Skip to content

Effectiveness of a Buteyko-based Breathing Technique for Asthma Patients

Effectiveness of a Buteyko-based Breathing Technique on Psycho-physiological Parameters of Adults With Asthma - a Randomized, Controlled Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03098849
Enrollment
63
Registered
2017-04-04
Start date
2017-01-25
Completion date
2017-10-26
Last updated
2018-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

Buteyko-based breathing technique training

Brief summary

The purpose of this study is to investigate the effects of a Buteyko-based breathing technique on physiological and psychological parameters in adults with asthma

Detailed description

The investigators explore the effects of a Buteyko-based breathing technique training using a treatment group vs. control group design and a repeated measures design with follow-up measurements 3 and 6 months after the intervention. The sample size calculation was made for an effect of d = .20 with repeated measures, a power of 1- β = .80 and α = .05. Additionally the investigators plan to take measurements (only once) from healthy volunteers matching them (age and gender) with the asthma patients.

Interventions

Patients are trained in various exercises aiming at breath reduction and breath control as introduced by Dr. K. Buteyko

Sponsors

University Hospital Tuebingen
CollaboratorOTHER
ARCIM Institute Academic Research in Complementary and Integrative Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Written informed consent, regular intake of prescribed asthma medication according to the AWMF scheme level 1, native speaker of german

Exclusion criteria

* Participation in another study, comorbidities (heart diseases, cancer still under treatment, psychiatric diseases)

Design outcomes

Primary

MeasureTime frameDescription
Change in Endtidal CO2Between baseline and 3 month follow upCapnometry
Change in Nijmegen-ScoreBetween baseline and 3 month follow upQuestionnare assessing hyperventilation
Change in Buteyko CPBetween baseline and 3 month follow upBreath hold test

Secondary

MeasureTime frameDescription
Heart Rate Variability (SDNN)Between baseline and 3 month follow upSDNN
Heart Rate Variability (RMSSD)Between baseline and 3 month follow upRMSSD
Heart Rate Variability (LF/HF)Between baseline and 3 month follow upLF/HF
Vascular stiffnessBetween baseline and 3 month follow upPulse Wave Velocity
Blood PressureBetween baseline and 3 month follow upSystolic and Diastolic
Haemodynamics Stroke volumeBetween baseline and 3 month follow upStroke volume
Haemodynamics Cardiac outputBetween baseline and 3 month follow upCardiac output
Haemodynamics Total Vascular ResistanceBetween baseline and 3 month follow upTotal Vascular Resistance
Haemodynamics Cardiac indexBetween baseline and 3 month follow upCardiac index
Spirometry: FEV1Between baseline and 3 month follow upFEV1
Haemodynamics PlethvariabilityBetween baseline and 3 month follow upPlethvariability index (PVI)
Oxygen SaturationBetween baseline and 3 month follow upSpO2
ACQBetween baseline and 3 month follow upAsthma Control Questionnaire, E. Juniper
AQLQBetween baseline and 3 month follow upAsthma Quality of Life Questionnaire, E. Juniper
ARCIM QuestionnaireBetween baseline and 3 month follow upQuestionnaire focusing on respiratory complaints like mucus, snoring, blocked nose.
STAI QuestionnaireBetween baseline and 3 month follow upState and Trait Anxiety Inventory
ASF QuestionnaireBetween baseline and 3 month follow upAachener Selbstwirksamkeitsfragebogen
Asthma medicationBetween baseline and 3 month follow upKind and dosage of asthma specific medication like steroids or betamimetics
Haemodynamics PerfusionBetween baseline and 3 month follow upPerfusion index
Spirometry: FEV1/VCinBetween baseline and 3 month follow upFEV1/VCin
Spirometry: PEFBetween baseline and 3 month follow upPEF

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026